International multicenter randomized double-blind placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol® and Mexidol® forte 250 in patients with chronic brain ischemia (MEMO): subanalysis in patients with arterial hypertension
This article is in “Library” – “Neurology” – “CCR: Chronic cerebrovascular disorder” section.
Author:
ZAKHAROV V.V.1, OSTROUMOVA O.D.1,2, KOCHETKOV A.1,2, KLEPIKOVA M.V.2, FEDIN A.1,3
1I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University)
2Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of Russia, Moscow
3N.I. Pirogov Russian National Research Medical University of the Ministry of Healthcare of Russia, Moscow